In 40 seconds
Vascular dementia accounts for about 17% of UK dementia cases and stems from chronic small-vessel brain disease. The underlying mechanism — impaired cerebral microcirculation — matches PEMF therapy's strongest action (microcirculation improvement). Direct vascular dementia evidence is limited but mechanism is plausible. Always alongside cardiovascular risk factor management (BP, cholesterol, diabetes, smoking) and memory clinic care.
Quick facts
- UK prevalence: ~17% of dementia cases
- Cause: Chronic small-vessel cerebral disease
- PEMF mechanism match: Strong — microcirculation improvement
- Cardiovascular management: Foundation
- Always with: Memory clinic + GP-led CV risk management
How PEMF may help
Vascular dementia is preventable in many cases through cardiovascular risk reduction. Once established, slowing progression depends on continued risk factor control and supporting brain blood flow. PEMF's microcirculation effects are mechanistically aligned.
Practical use
2-3 sessions per week for 8 weeks alongside specialist care. Cardiovascular risk factor optimisation remains primary.
Contraindications
Standard PEMF contraindications: pacemakers, defibrillators, cochlear implants, insulin pumps, electronic implants; active malignancy without specialist clearance; pregnancy (over the abdomen); active infection; epilepsy without GP clearance.
Frequently asked questions
Better for vascular dementia than Alzheimer's?
Mechanism is more directly aligned. But always alongside specialist care.
Will it stop progression?
Cardiovascular risk control is the foundation. PEMF supports brain microcirculation but doesn't replace BP/cholesterol/diabetes management.
Looking for a PEMF clinic near you?
We list every credible PEMF therapy provider in the UK so you can find one near home.